Alphee Cazenave (1842) separated noli me tangere from lupus, regarding the former as a cancerous process. He wrote: "Under the term 'noli me tangere' have been confounded lupus and cancerous affections of the face but they differ essentially from one another. Lupus seldom occurs in persons of advanced age like noli me tangere. Lupus starts with several indolent tubercles which form dry, thick scabs. Noli me tangere begins as a single tubercle with a hard circumscribed edge, lancinating pains, inflammatory swelling of the soft parts, proceeding to painful everted fungous ulcers and destroying deep-seated parts of the face. It is exasperated by caustics." Erasmus Wilson (1857) referred to three classes of lupus, namely lupus erythematosus, lupus non-exedens, and lupus exedens, the last-named being synonymous, according to Jonathan Hutchinson (1883-84), with rodent ulcer, although it may also have been applied to ulcerated lupus, infected with cocci, or to lupus complicated by cancer.
Jonathan Hutchinson is generally credited with having been the first to describe the apple-jelly nodule-the elementary lesion of lupus, but in 1865 he wrote: "Patches of lupus often present a very peculiar tint; they are at parts glossy and semi-transparent. Mr. Wilson has well compared them to 'reddish transparent jelly effused upon the skin, and streaked with the ramifications of a few small blood vessels'. In many conditions they remind me more of a bruise in the rind of an apple than anything else. Often a patch looks a little depressed, just like a bruise or decayed spot, there being for the present no trace of tubercles." Paul IUnna described the method of examination of lupus nodules under-glass pressure (diascopy). Matthew Purmann (1706) listed the theories of the Ancients as to the cause of herpes esthiomenos.
ITS NATURE
For example, Paraeus had regarded it as "a tumour caused by a subtle mixture of choler, phlegm, -and melancholy". Purmann himself regarded lupus as "accompanied with the scurvy, an ill-cured gonorrhcea or Morbus Gallicus". Antoine Lorry (1777) mentioned scrofula as a cause in a minority of cases. He appreciated that lupus could cause lymph stasis and elephantiasis. Pierre Rayer in 1826 pointed out that lupus especially affected scrofulous children but that it could also attack robust persons who had been in excellent health all their lives. The ulcerations of lupus were seldom successfully treated during the winter. Tilbury Fox in 1864 held the view that "lupus has some unequivocal affinities with scrofulous caries of bone, scrofulous disease of the skin, and tuberculous ulceration of the lungs".
Jonathan Hutchinson (1865) wrote: "There can, I think, be little doubt that it is more or less connected with the tubercular diathesis. It is common in cases of lupus to find a history of phthisis in some of the patient's near relatives."
In 1881-82 Henry Leloir demonstrated the inoculability of lupus and concluded that it was a slightly virulent tuberculosis of the integument. In 1883 Robert Koch discovered tubercle bacilli in lupus, and in 1884 he inoculated a series of animals with bacilli from lupus tissue, tuberculosis resulting.
ITS TREATMENT
From the earliest times the importance of general hygienic measures was recognized. Thus, Purmann (1706) wrote: "Cure begins with gentle Laxatives and Sudorificks. The patient must also observe a good Diet, live temperately, and observe everything the Physician or Chirurgeon directs for his Recovery." CAUSTICS.
Local treatment was for long limited to caustics, of which arsenic was the favourite. It was sometimes included in the guise of an adjuvant to an inert substance posing as the active principle.
In the New London Dispensatory, 1676, dedicated to King Charles II, there is a remedy savouring of "similia similibus curantur", although it precedes the birth of Samuel Hahnemann, the founder of homceopathy, by no less than eighty years. It was called "Quintessence of Wolf's Flesh" and consisted of "E Wolf's flesh, newly killed .. lb By the early part of the nineteenth century, the pat6 arsenicale de Frere Come was widely used. -"Brother Jean de St. C6me (1703-1781) was a French surgeon, Jean Baseilhac, who became a monk. s paste consisted of arsenious acid, red sulphide of mercury, and burnt sponge; it was never applied to an area larger than a shilling and its use was often followed by erysipelas which, according to Cazenave, was "sometimes slight but occasionally very severe and attended by enormous swelling of the face and violent headache". C6me's paste was reserved for old and obstinate cases.
Another widely used caustic was Dupuylren's powder of 199 parts of calomel with I part of white oxide of arsenic. This was less powerful than Come's paste but nevertheless an opiate often had to be administered during its use. According to Cazenave, it was "suited to slight cases of the disease, occurring in children, females, or persons of irritable habit".
In the eighteenth century another much used application was the Animal Oil of Dippel, or rectified oil of hartshorn. According to Cazenave the oil acted more as an irritant than as a caustic.
Cheaper substitutes often seem to have been used. In the Edinburgh New Dispensatory of 1816 it was stated: "If hartshorn cannot be had, the bones of any other land animal may be substituted for them." Pierre Rayer recommended the application of one or two leeches to each tubercle, if the sufferer was not scrofulous.
Towards the end of the nineteenth century, Vienna paste came into use. It consisted of equal parts of caustic potash and quicklime in powder, with a few drops of rectified spirit and, like Canquoin's paste of equal parts of chloride of zinc and oxide of zinc, was so powerful that Balmanno Squire might well write of them: "These pastes require to be handled with great caution." Many other substances have been used at one time or another as iritants or caustics. Bier's method of congestion was also sometimes used. The cautery has been used for treating lupus from early times but Rayer advised that it "should never be had recourse to in large ulcers of lupus on the nose. When it has been employed the bones and cartilages of the nose have been known to *well and to become attacked by chronic inflammation from which they were previously free".
Sedtion of the History of Medicine
In 1899 Paul ILnna was using a wood spicule method in which strong mercury and carbolic lotions were twisted into the nodules on spicules and left in position, six at one session. The "patch of thorns" was covered with a mercury and carbolic plaster for two days, after which the lupus nodules were found to be converted into pustular depressions.
About the same time, Hollander's hot air treatment was introduced, in which a metal tube ; in.
in diameter with a nozzle, was connected to a pump and a Bunsen burner. The air was heated to 300°C. The lupus tissue was described as appearing to crackle, the patch becoming blanched from ischemia. The pain must have been intense, and ugly scarring resulted.
SURGERY.
Surgery, too, has been used from the earliest times. Bateman (1829) wrote: "By surgical means, that is by the knife, or the caustic, a separation has sometimes been made of the morbid from the sound parts, and the progress of the disease arrested."
Lang of Vienna was the chief protagonist of treatment by excision, but recurrences were common. Balmanno Squire (1888) invented a multiple linear scarifier with 17 blades in a handle j in. wide which made incisions "methodically separated by interspaces sufficiently broad to avoid the risk of mortification".
The Volkmann spoon was often used for curetting out the diseased tissue; or "puncturation" in which innumerable punctures were made with the point of a lancet, and the skin minutely minced even to mortification. IRRADIATION.
The most important advance in the treatment of lupus was the discovery by Niels Finsen of t-he effects of ultraviolet irradiation on lupus nodules. In 1895, Thayer had used solar rays concentrated by a powerful convex lens, but his apparatus was essentially a burning glass and Finsen in 1897 made the first report of the effects of solar irradiation with the heat rays excluded, by the interposing of a solution of ammoniacal copper sulphate between two lenses (Fig. 1 ). Finsen next devised,an apparatus consisting of an arc iamp, a heat-extracting system, lenses for concentra ting the rays, and a translucent applicator with which to express the blood from the area of skin being treated. This lamp was the outcome of four yea'rs of experimentation in which he constructed some 20 different models of arc lamps. In the Finsen lamp the arc and the applicator had to be kept in alignm'ent by an attendant (Fig. 2) . The Finsen-Reyn lamp and a London Hospital modification of it were designed to get over these difficulties and finally the Finsen-Lomholt lamp was designed by Lomholt, head of the Finsen Institute. This lamp had the gre'at advantage that the arc, concentration and compression systems were incorporated in one unit. Three lamps could be supervised by one attendant. Each treatment lasted half an hour, whereas Finsen lamp treatments had taken two hours.I In 1922 Reyn introduced treatment by general carbon arc irradiation as an adjunct to local Finsen treatment. Sequeira and O'Donovan found that a cure rate of about 76 % with the Finsen lamp was raised to about 90 %~by this combi'ned treatment, and progress was as good in winter as in summer.
Mercury vapour lamps (for example the Kromayer lamp) have not proved as efciea abn arc lamp's. They are poor emitters of the effective longer u'ltraviolet rays. In 1901 Freund and Schiff of Vienna first used X-rays against lupus vulgaris. Sequeira reminiscing many years later wrote: "We worked on the trial and error system, little realizing the risks both operator and patient were running. All we had learned was that applications of the rays might be followed by fall of hair, for the measurement of dosage did not come into general use until about 1904. Our patient was placed about 6 in. from the tube. A ten-minute sitting was given and this was repeated daily until something happened."
In 1903 Danlos used radium and in 1939 Spiethoff reported good results from the use of Grenz rays.
TUBERCULIN.
Koch's original tuberculin (a glycerol extract of cultures of tubercle bacilli) was introduced in 1890. Its use was quickly condemned by th-French school. There were alarming general reactions, even deaths, and according to Thibierge (1E 91) after a visit to Berlin "not a single case even apparently cured".
In 1897 Koch's new tuberculin (a g'ycerol-water suspension of dried and pulverized bacilli) was introduced and has been advocated by several physicians, including Morris (1904) , Western (1909) and Semon and Burnell-Jones (1934'. Morris thought it modified the disease process so as to make it more amenable to local treatment. Semon went so far as to recommend the establishment of special tuberculin treatment centres. As recently as 1946 Aitken thought it the remedy of choice if treatment by general ultraviolet rays was not available, and provided there was no pulmonary tuberculosis.
INTERNAL REMEDIES.
Bateman wrote: "I can mention no medicine which has been of any essential service in the cure of it."
Rayer advocated bitters and a strengthening diet and added that "if the state of the digestive organs admitted, there is sometimes benefit obtained by causing a temporary revulsion towards those parts, as by muriate of barytes or of lime". He thought tonic treatment as adapted to scrofula appeared the best to effect the resolution of the tubercles and prevent ulceration.
Arsenic was much favoured in the form of Feltz's decoction, Asiatic pills, Pearson's solution, or Fowler's solution; but Rayer wrote that "it was not until these dangerous medicaments have been administered for several months that their utility becomes manifest; they more frequently prove useless or injurious". The animal oil of Dippel was often used internally as well as externally. Erasmus Wilson (1857) wrote: "M. Lemery, of St. Louis Hospital, had recourse to cod-liver oil, of which he speaks in the most encouraging terms. He begins with the dose of an ounce three times a day, increasing the quantity for fifteen days, by which time he reaches 6 oz. a dose. If the disease exhibit no indication of submission, he goes on until he arrives at 2 pints in the day. Should the stomach revolt, a glass or two of Seltzer water is given, and if any symptoms of derangement of the alimentary canal or fever supervene, the oil is suspended but continued again at the minimum dose as soon as the symptoms disappear." Two pints of cod-liver oil are equivalent to 100,000 units of vitamin D. Tilbury Fox (1864) wrote: "Cod-liver oil is the sheet anchor in lupus." But Ferdinand von Hebra and Moritz Kaposi (1875) regarded it and all other internal remedies as quite inert. Lugol's iodine was sometimes given with considerable success. The Gerson diet was favoured by some. It mainly consisted of salt-free, uncooked food. Jesionek and Bernhardt (1930) developed this treatment further; the diet was rich in fresh foods of high vitamin content and this may well have accounted for much of the success that was obtained.
In 1943 Charpy in France and in 1945 Dowling and Prosser Thomas in England reported the value of calciferol (vitamin D2) when given in massive doses. Charpy gave injections of 600,000 units once or twice a week, while Dowling and Prosser Thomas relied on oral treatment, 150,000 units being taken daily. This treatment linked up with the well-known tendency of lupus to improve in summer; with Lemery's treatment by massive dosage with cod-liver oil; and with Reyn's general carbon-arc baths.
A 50% clinical cure rate was claimed for calciferol, with improvement of most of the remainder. The histological cure rates were much lower. Vachon and Feroldi (1945) pointed out that the treatment only brought about enclosure of tuberculous foci by young connective tissue, followed by fibrosis; the foci did not disappear. Joppe (1950) obtained positive results from animal inoculation with material from clinically cleared lupus nodules. The disadvantages of calciferol treatment include its toxicity and the inadvisability of using it in pregnancy or when pulmonary tuberculosis, renal disease or hypertension coexist. Calciferol is also effective, and relatively harmless, when injected directly into the lupus nodules (Jensen, 1948) . Injection of the oily vehicle alone is without effect; yet calciferol dissolved in this vehicle and injected into another part of the same nodule, causes a severe reaction, even proceeding to ulceration (Russell, 1951) .
It seems that calciferol acts indirectly, by stimulating the tissues of the host to react to one of the constituents of the lipid envelope of the tubercle bacillus, possibly phthioic acid.
Van der Lugt (1952) has shown that exposure to the Finsen light increases the local concentration of vitamin D in the skin.
Calciferol has been given with streptomycin by Cornbleet (1949) and others for resistant or secondarily infected lupus. Streptomycin alone, or with para-aminosalicylic acid has not come into favour in the treatment of lupus. The development of isoniazid is the result of years of intensive study by many workers, in particular, Chorine, Domagk, Fox, Girard, and Robitzek. Domagk (1946, 1948) found slight antituberculous activity in sulphathiazole and from this went on to develop first sulphathiadiazole which had greater activity and then an even more powerful open chain analogue, thiacetazone (p-acetylamino benzaldehyde thiosemicarbazone) designated by Domagk T B 1 or Conteben. It did not come into general use because it was often not tolerated.
In 1944-45, Chorine had found that nicotinamide possessed antituberculous bacteriostatic properties and he was able to demonstrate that it retarded the tuberculous process in guinea-pigs;
isonicotinamide was found to be inactive in this respect.
In 1950, Levaditi, Girard, Vaisman and Roy combined nicotinamide with thiosemicarbazone to make the nicotinic aldehyde of thiosemicarbazone. It was shown to be effective in vitro and in experimental tuberculosis but it often caused digestive disturbances and was not well tolerated. Meanwhile Fox (1951) had been synthesizing and testing a large number of thiosemicarbazones. He reported that the isonicotinic aldehyde of thiosemicarbazone was superior to the nicotinic aldehyde as regards antituberculous activity. Domagk, continuing his studies, noted the remarkable activity of isonicotinic acid hydrazide. Robitzek et al. (1952) reported the efficacy of isonicotinic acid hydrazide in human tuberculosis and its isopropyl derivative was synthesized and found to be highly effective in a dose of 8 mg. per kg. body weight. In a dose of 300-400 mg. per diem (about 8 mg. per kg. body weight) which is substantially lower than the toxic level, isoniazid induces a steady involution of the nodules of lupus until after about six months there is clinical clearance. Histological clearance goes hand in hand with clinical clearance. Isonicotinic acid hydrazide acts on the tubercle bacilli in bactericidal fashion. There is no stimulation of the host's tissue reactions as with calciferol. Patients with lupus vulgaris have attenuated bacilli in the skin and they are highly resistant against pulmonary infection with tubercle bacilli, as witness the rarity of pulmonary tuberculosis in sufferers from lupus-less than 2% according to Aitken (1946) . For these reasons, some dermatologists have thought it unnecessary to give other anti-tuberculous substances with isoniazid. Meyer-Rohn and Schulz (1954) claim to have cultured virulent tubercle bacilli from excised skin of clinically healed lesions which showed on section no evidence of a tuberculous histology, from patients treated with isoniazid. PREVENTION It would not be right to conclude without paying tribute to the great success of preventive measures directed against tuberculosis, including lupus. The incidence of fresh cases of lupus attending outpatient clinics is about one-tenth of that quoted for thirty years ago.
Pasteurization of milk has probably contributed most to this reduction, some 52 % of cases having been attributed to bovine tubercle bacilli in the past (Aitken, 1946) . Other factors have been better nutrition, housing, clothing and hygiene; the earlier recognition of pulmonary tuberculosis; the increased use of vacuum cleaners instead of manual dusting; and cleaner methods by tattoo "artists". Present dangers, though rare, include BCG vaccination (Marcussen, 1954) and swimming baths (Hellerstrom, 1951; Cleveland, 1951) : in some examples of cutaneous granulomata acquired from swimming baths M. tuberculosis has been identified but in others (Linnell and Norden, 1954) acid-fast organisms, growing better at 300 C. and called by Swedish workers M. balnei, have been incriminated. The day when the townsman's skin is no longer shut off from the ultra-violet rays of the sun by the sulphurous pall of industrial and domestic smokes is yet to come.
